Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Trevena Inc. (TRVN)

2.99   0.01 (0.34%) 10-01 09:24
Open: 2.96 Pre. Close: 2.98
High: 3.03 Low: 2.87
Volume: 5,073,640 Market Cap: 459M
Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. The company is headquartered in Chesterbrook, Pennsylvania and currently employs 29 full-time employees. The firm is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. The company is focused on commercializing it in the United States for use in acute care settings, such as hospitals and ambulatory surgery centers. The company is also developing TRV250, a G protein biased ligand targeting the o-receptor, as a compound with a non-narcotic mechanism for the treatment of migraine. TRV250 also may have utility in a range of other central nervous system (CNS) indications. The company is focused on commencing a Phase I study of TRV250 in the United Kingdom. Its ABLE product platform is a collection of biological information, in vitro assays, know-how and expertise that it uses to identify unique G protein coupled receptors (GPCR)-targeted biased ligands with various pharmaceutical properties.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.034 - 3.046 3.046 - 3.058
Low: 2.84 - 2.854 2.854 - 2.866
Close: 2.968 - 2.99 2.99 - 3.01

Technical analysis

as of: 2020-09-30 4:47:17 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.68     One year: 4.30
Support: Support1: 2.11    Support2: 1.47
Resistance: Resistance1: 3.15    Resistance2: 3.68
Pivot: 2.51
Moving Average: MA(5): 2.87     MA(20): 2.30
MA(100): 1.84     MA(250): 1.20
MACD: MACD(12,26): 0.27     Signal(9): 0.19
Stochastic oscillator: %K(14,3): 85.15     %D(3): 81.56
RSI: RSI(14): 71.55
52-week: High: 3.68  Low: 0.46  Change(%): 182.1
Average Vol(K): 3-Month: 1171430  10-Days: 981146

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TRVN has closed below upper band by 21.2%. Bollinger Bands are 103.2% wider than normal. The large width of the bands suggest high volatility as compared to TRVN's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Wed, 30 Sep 2020
Trevena's Shares March Higher, Can It Continue? - Yahoo Finance

Wed, 30 Sep 2020
Here is why Trevena Inc. (TRVN) recent weekly performance of 4.20% shouldn’t bother you at All - The InvestChronicle

Tue, 29 Sep 2020
The Rejuvenation of Trevena Inc. (NASDAQ:TRVN) - The Oracle Dispatch

Fri, 25 Sep 2020
Should You Buy Trevena Inc (TRVN) Stock? - InvestorsObserver

Mon, 21 Sep 2020
A Little Luck Can Go a Long Way with Trevena Inc. (TRVN) as it 5-day change was 46.07% - News Daemon

Mon, 21 Sep 2020
Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 153
Shares Float (M) 130
% Held by Insiders 3.06
% Held by Institutions 20.53
Shares Short (K) 13,620
Shares Short P. Month (K) 8,620

Stock Financials

EPS -0.274
EPS Est This Year -1.360
EPS Est Next Year -0.930
Book Value (p.s.) 0.440
Profit Margin
Operating Margin -88183.87
Return on Assets (ttm) -26.0
Return on Equity (ttm) -55.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.175
Qtrly Earnings Growth
Operating Cash Flow (M) -25
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -10.91
PEG Ratio
Price to Book value 6.80
Price to Sales 14792.78
Price to Cash Flow -18.72

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.